Abiopharma

Beneficient Reports First Quarter Fiscal 2027 Results

Lantern Pharma Reports Second Quarter 2026 Financial Results and Provides Business Update

U.S. Physical Therapy Announces CFO

FORM 4 - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Simon Zehava

Helus Pharma Reports First Quarter Fiscal 2027 Financial Results and Recent Business Highlights

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Disclosure of Interest of Substantial Shareholder - Temasek Holdings (Private) Limited

Boost Run Secures Long-Term Lease with 10X Capital to Expand GPU Compute Capacity

Asset Acquisitions and Disposals: ANNOUNCEMENT PURSUANT TO RULE 706A OF THE LISTING MANUAL

Asset Acquisitions and Disposals: ANNOUNCEMENT PURSUANT TO RULE 706A OF THE LISTING MANUAL OF SGX

Financial Statements and Related Announcement: Half Yearly Results